Avience Biomedicals
Ticker > Company >

Avience Biomedicals share price

Avience Biomedicals Ltd.

 246   0   0

The company is currently not listed and is under IPO, so all the data might not be available.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year77.73%
3 Year41.73%
5 YearNA

Profit Growth

1 Year160.44%
3 Year93.37%
5 YearNA

ROE%

1 Year38.95%
3 Year33.68%

ROCE %

1 Year31.57%
3 Year27.5%

Debt/Equity

0.6674

Price to Cash Flow

0

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

 Strengths

  • The company has shown a good revenue growth of 41.7290275224814% for the Past 3 years.
  • Company has been maintaining healthy ROE of 33.6824666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 27.4965333333333% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • Company has low Interest coverage ratio of 0.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 10.15 10.92 16.26 28.89
Total Expenditure 8.93 9.49 13.08 21.21
Operating Profit 1.22 1.43 3.17 7.68
Other Income 0 0.01 0.38 0.65
Interest 0.16 0.27 0.44 0.64
Depreciation 0.09 0.2 0.44 0.73
Exceptional Items 0 0 0 0
Profit Before Tax 0.97 0.96 2.68 6.96
Tax 0.25 0.18 0.69 1.77
Net Profit 0.72 0.78 1.99 5.19
Adjusted EPS (Rs.) 2.72 2.38 6.07 12.88

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 2.03 3.28 3.28 4.03
Total Reserves 0.76 0.79 2.79 16.57
Borrowings 0.17 0.15 1.27 6.29
Other N/C liabilities 0.04 0.06 0.12 0.21
Current liabilities 3.09 5.73 18.17 16.51
Total Liabilities 6.1 10.02 25.63 43.6
Assets
Net Block 1.17 2.52 6.82 8.86
Capital WIP 0 0 0.03 4.62
Intangible WIP 0 0 0 0
Investments 0 0 5.73 5.73
Loans & Advances 0.37 0.5 0.61 1.17
Other N/C Assets 0 0.11 0.26 0.02
Current Assets 4.56 6.88 12.18 23.2
Total Assets 6.1 10.02 25.63 43.6
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2024 Mar 2025
Profit from operations 2.68 6.96
Adjustment 0.79 1.26
Changes in Assets & Liabilities -3.12 -4.43
Tax Paid -0.12 -0.65
Operating Cash Flow 0.23 3.14
Investing Cash Flow -4.12 -8.16
Financing Cash Flow 3.8 9.06
Net Cash Flow -0.09 4.04

Corporate Actions

Company News

 No Latest News available for this company.Report us
Last Updated on:
Brief about Avience Biomedicals
X